BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 16127016)

  • 1. Involvement of innate immunity in the development of inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Tucková L; Stepánková R; Hudcovic T; Palová-Jelínková L; Kozáková H; Rossmann P; Sanchez D; Cinová J; Hrncír T; Kverka M; Frolová L; Uhlig H; Powrie F; Bland P
    Ann N Y Acad Sci; 2005 Jun; 1051():787-98. PubMed ID: 16127016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.
    Mencarelli A; Renga B; Palladino G; Distrutti E; Fiorucci S
    Biochem Pharmacol; 2009 Nov; 78(9):1214-23. PubMed ID: 19555671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
    Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
    Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammatory bowel disease: IBD].
    Endo K; Shiga H; Kinouchi Y; Shimosegawa T
    Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity in inflammatory bowel disease: state of the art.
    Hisamatsu T; Ogata H; Hibi T
    Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?
    Reuter BK; Pizarro TT
    Eur J Immunol; 2004 Sep; 34(9):2347-55. PubMed ID: 15307167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota.
    Elson CO; Cong Y; McCracken VJ; Dimmitt RA; Lorenz RG; Weaver CT
    Immunol Rev; 2005 Aug; 206():260-76. PubMed ID: 16048554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse models of inflammatory bowel disease.
    Wirtz S; Neurath MF
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1073-83. PubMed ID: 17825455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity, inflammation, and allergy in the gut.
    Macdonald TT; Monteleone G
    Science; 2005 Mar; 307(5717):1920-5. PubMed ID: 15790845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of mucosal microbiota with the innate immune system.
    Tlaskalova-Hogenova H; Tuckova L; Mestecky J; Kolinska J; Rossmann P; Stepankova R; Kozakova H; Hudcovic T; Hrncir T; Frolova L; Kverka M
    Scand J Immunol; 2005 Jul; 62 Suppl 1():106-13. PubMed ID: 15953193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological disorders in inflammatory bowel disease and immunotherapeutic implications.
    Amati L; Caradonna L; Jirillo E; Caccavo D
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):313-25. PubMed ID: 10425578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation.
    Xu Y; Hunt NH; Bao S
    Cell Res; 2008 Dec; 18(12):1220-9. PubMed ID: 19030026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, innate immunity and gut inflammation.
    Karagiannides I; Pothoulakis C
    Curr Opin Gastroenterol; 2007 Nov; 23(6):661-6. PubMed ID: 17906444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of inflammatory bowel disease in a mouse model of depression.
    Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
    Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives.
    Neurath MF
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):81-4. PubMed ID: 10807047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of experimental colitis by intestinal mononuclear phagocytes.
    Qualls JE; Kaplan AM; van Rooijen N; Cohen DA
    J Leukoc Biol; 2006 Oct; 80(4):802-15. PubMed ID: 16888083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiac disease: from pathogenesis to novel therapies.
    Schuppan D; Junker Y; Barisani D
    Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate and adaptive immunity: the yin and yang of celiac disease.
    Jabri B; Kasarda DD; Green PH
    Immunol Rev; 2005 Aug; 206():219-31. PubMed ID: 16048552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of mucosal immunity in a murine model of food-induced intestinal inflammation.
    Cardoso CR; Teixeira G; Provinciatto PR; Godoi DF; Ferreira BR; Milanezi CM; Ferraz DB; Rossi MA; Cunha FQ; Silva JS
    Clin Exp Allergy; 2008 Feb; 38(2):338-49. PubMed ID: 18005184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.